| Literature DB >> 25130212 |
S E K Fink1, M K Gandhi, J P Nourse, C Keane, K Jones, P Crooks, K Jöhrens, A Korfel, H Schmidt, S Neumann, A Tiede, U Jäger, U Dührsen, R Neuhaus, M Dreyling, K Borchert, T Südhoff, H Riess, I Anagnostopoulos, R U Trappe.
Abstract
Primary central nervous system (pCNS) posttransplant lymphoproliferative disorder (PTLD) is a complication of solid organ transplantation characterized by poor outcome. In contrast to systemic PTLD, Epstein-Barr virus (EBV)-association of pCNS PTLD is almost universal, yet viral and cellular data are limited. To identify differences in the pattern of EBV-association of pCNS and systemic PTLD, we analyzed the expression of latent and lytic EBV transcripts and the viral and cellular microRNAome in nine pCNS (eight EBV-associated) and in 16 systemic PTLD samples (eight EBV-associated). Notably although 15/16 EBV-associated samples exhibited a viral type III latency pattern, lytic transcripts were also strongly expressed. Members of the ebv-miR-BHRF1 and ebv-miR-BART clusters were expressed in virtually all EBV-associated PTLD samples. There were 28 cellular microRNAs differentially expressed between systemic and pCNS PTLD. pCNS PTLD expressed lower hsa-miR-199a-5p/3p and hsa-miR-143/145 (implicated in nuclear factor kappa beta and c-myc signaling) as compared to systemic PTLD. Unsupervised nonhierarchical clustering of the viral and cellular microRNAome distinguished non-EBV-associated from EBV-associated samples and identified a separate group of EBV-associated pCNS PTLD that displayed reduced levels of B cell lymphoma associated oncomiRs such as hsa-miR-155, -21, -221 and the hsa-miR-17-92 cluster. EBV has a major impact on viral and cellular microRNA expression in EBV-associated pCNS PTLD. © Copyright 2014 The American Society of Transplantation and the American Society of Transplant Surgeons.Entities:
Keywords: Kidney transplantation/nephrology; molecular biology: micro RNA; posttransplant lymphoproliferative disorder (PTLD); translational research/science
Mesh:
Substances:
Year: 2014 PMID: 25130212 DOI: 10.1111/ajt.12858
Source DB: PubMed Journal: Am J Transplant ISSN: 1600-6135 Impact factor: 8.086